Generally, the role of S100A8 in multiple tumors is highlighted as a promotor of tumor invasion, TME formation, and drug resistance (14, 16, 28), however, there has been no direct report on relationship between S100A8 and DLBCL. This evidence concerns the gene S100A8 and neoplasm.